clinical laboratory News
-
Join Us in Atlanta with Our Complimentary Clinical Expo Badge
Despite the challenges, our global laboratory community is more united and determined than ever. The in-person is now possible again. And we can’t wait to meet you in Atlanta! Claim your complimentary Clinical Lab Expo pass and join your community for clinical laboratory science education, problem-solving and networking at the 2021AACC Annual Scientific Meeting & Clinical Lab Expo. ...
-
Selfdiagnostics began development of a rapid SARS-CoV-2 test which enables faster detection of coronavirus infection at a lower price.
The new rapid test will significantly increase testing capacity and deliver greater resource efficiency. The project has been awarded an EIT Health product development grant by the European Institute of Innovation and Technology. The rapid test provides a lab-in-your-pocket solution which guarantees mobile testing capability based on the PCR (polymerase chain reaction) technique. The test kit can ...
-
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
GRAIL, LLC, a healthcare company whose mission is to detect cancer early, today announced that the New York State Department of Health (NYSDOH) has approved Galleri™, GRAIL’s groundbreaking multi-cancer early detection blood test. With NYSDOH approval, Galleri is now available to residents in the state of New York by prescription to complement existing single cancer screening tests. ...
By Grail, Inc.
-
Training and consultancy for Analyse-it
Our focus at Analyse-it has always been on the development and improvement of our software. While we provide extensive help, tutorials, and technical support for Analyse-it, one area we do not cover is training and consultancy. As many of you will know we are based in England in the United Kingdom, and providing training and consultancy is often done better locally, in-person. Instead we ...
-
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories
Thermo Fisher Scientific has expanded its portfolio of analytical instruments for clinical diagnostic laboratories with the addition of three systems now listed as Class I medical devices with the United States Food and Drug Administration (U.S. FDA). The portfolio enables clinical diagnostic laboratories to leverage a comprehensive platform for developing sensitive and reliable laboratory ...
-
Thermo Fisher Scientific Launches CE/IVD Marked Immunosuppressants Panel for the Cascadion SM Clinical Analyzer
Thermo Fisher Scientific, the world leader in serving science, announced today that it has expanded its European offering of pre-validated assays for the Thermo Scientific Cascadion SM Clinical Analyzer with the addition of the CE/IVD marked Cascadion SM Immunosuppressants (ISD) Panel. Clinical laboratories can now access a complete system developed to enable simultaneous testing of cyclosporine ...
-
Empowering Patient Care: Global Medical Kiosks Market Poised for Remarkable 14.8% CAGR, According to BCC Research
Boston: “According to the latest BCC Research study, the demand for Medical Kiosks: Global Market and Forecasts is estimated to increase from $1.4 billion in 2022 to reach $3.2 billion by 2028, at a compound annual growth rate (CAGR) of 14.8% from 2022 through 2028.” The comprehensive report on the medical kiosks market delivers a thorough analysis of its current landscape and future ...
By BCC Research
-
SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies
SAGA Diagnostics AB (“SAGA”), a cancer liquid biopsy and genomic testing company, today announced that it has raised SEK 106 million (€10.5 million) in a Series A2 financing from both existing and new investors. The Series A2 round was led by Segulah Medical Acceleration and the Sciety investment syndicate with strong support from existing shareholders such as Hadean Ventures. ...
-
Waters ACQUITY UPLC I-Class/Xevo TQ-S micro System available as a U.S. FDA Class I, CE-Marked Medical Device
Waters Corporation (NYSE: WAT) today announced that the Waters® ACQUITY UPLC® I-Class IVD/Xevo® TQ-S micro IVD System is now manufactured as a U.S. FDA Class I medical device and is CE Marked to the European Directive 98/79/EC (IVDD). This development allows clinical laboratories to access leading innovations in liquid chromatography (LC) and mass spectrometry (MS) technology for the ...
-
Thermo Fisher Scientific Announces Collaboration with Ortho Clinical Diagnostics
Thermo Fisher Scientific, the world leader in serving science, today announced a collaboration with Ortho Clinical Diagnostics to promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for use with Ortho Clinical Diagnostics VITROS analyzers. Through this agreement, Ortho Clinical Diagnostics customers will have complete access to MAS third-party ...
-
HORIBA Medical welcomes the latest member of the new Yumizen H500 family
As a result of a growing research and development program, HORIBA Medical has recently developed two new products that aim to better meet the needs of today's clinical laboratories : The Yumizen H500 OT ‘Open Tube’ with flexible sampling to accommodate all sample types, particularly for rapid screening in critical care, emergency care and pediatric clinics. The new released ...
-
Castle Biosciences Receives Accreditation from the College of American Pathologists for its Pittsburgh Clinical Laboratory
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of American Pathologists (CAP) has accredited its clinical laboratory facility in Pittsburgh. This achievement follows a recent on-site inspection as part of the CAP’s Laboratory Accreditation Program. ...
-
New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth
As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD) system from Thermo Fisher Scientific will enable them to expand their assay menus and IVD testing capabilities moving forward. The Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System is a compact instrument that easily transitions from ...
-
Exposure to Organic Solvents Before First Childbirth May Increase Hormone-related Breast Cancer Risk
Among women with a family history of breast cancer, those who worked with organic solvents prior to their first full-term birth had an increased risk for hormone receptor-positive breast cancer, according to data published in Cancer Research, a journal of the American Association for Cancer Research. “The time between puberty and before first birth is an important period of development ...
-
Exposure to Organic Solvents Before First Childbirth May Increase Hormone-related Breast Cancer Risk
Among women with a family history of breast cancer, those who worked with organic solvents prior to their first full-term birth had an increased risk for hormone receptor-positive breast cancer, according to data published in Cancer Research, a journal of the American Association for Cancer Research. “The time between puberty and before first birth is an important period of development ...
-
Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories
Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust, reliable and sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows for clinical research applications. Bringing together Thermo ...
-
Cleveland Diagnostics Receives College of American Pathologists (CAP) Accreditation for Its Clinical Laboratory
Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that it has received Laboratory Accreditation from the College of American Pathologists (CAP) for its CLIA certified reference lab. The CAP Accreditation is awarded to laboratories that meet stringent requirements and maintain the ...
-
CMS provides flexibility for Medicare Advantage plans during COVID-19
Due to the COVID-19 pandemic, Centers for Medicare & Medicaid Services (CMS) recently implemented temporary rules and waivers surrounding Medicare Advantage plans. These rules now allow providers more flexibility to focus on caring for members affected by COVID-19. These temporary policy changes are now available to Medicare Advantage Organizations (MAOs) to essentially help prevent the ...
-
Live at Saint Mary’s Regional Health System
Today, Saint Mary’s Regional Health System in Russellville, Arkansas announced that its laboratory went clinically live with the Accelerate Pheno® system, taking a leap forward in its care for patients with bloodstream infections and sepsis. The four-module system will enable the laboratory’s microbiology team to deliver fast antimicrobial susceptibility test results to clinicians ...
-
Chronus Health Raises Series A Financing
Company poised to disrupt $80 billion U.S. clinical laboratory market Chronus Health, a point-of-care diagnostics company, announced today that it has raised $22 million Series A financing led by Tarsadia Investments with participation from Monta Vista Capital, SOSV, Savantus Ventures, and an undisclosed strategic investor. While several on-site blood analyzers are already available in the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you